Published in Breast Cancer Res on November 10, 2009
Down-regulation of 5-HT1B and 5-HT1D receptors inhibits proliferation, clonogenicity and invasion of human pancreatic cancer cells. PLoS One (2014) 1.39
Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev (2014) 1.07
Resting potential, oncogene-induced tumorigenesis, and metastasis: the bioelectric basis of cancer in vivo. Phys Biol (2012) 0.92
Tryptophan metabolism in breast cancers: molecular imaging and immunohistochemistry studies. Nucl Med Biol (2012) 0.91
Endogenous Voltage Potentials and the Microenvironment: Bioelectric Signals that Reveal, Induce and Normalize Cancer. J Clin Exp Oncol (2013) 0.90
Mammary gland serotonin regulates parathyroid hormone-related protein and other bone-related signals. Am J Physiol Endocrinol Metab (2012) 0.86
Identification of novel genetic alterations in samples of malignant glioma patients. PLoS One (2013) 0.85
Multiple cellular responses to serotonin contribute to epithelial homeostasis. PLoS One (2011) 0.82
The effect of PTEN on serotonin synthesis and secretion from the carcinoid cell line BON. Anticancer Res (2011) 0.81
BJ-1108, a 6-Amino-2,4,5-Trimethylpyridin-3-ol Analog, Inhibits Serotonin-Induced Angiogenesis and Tumor Growth through PI3K/NOX Pathway. PLoS One (2016) 0.80
Intraluminal volume homeostasis: A common sertonergic mechanism among diverse epithelia. Commun Integr Biol (2011) 0.80
Serotonin (5-HT) affects expression of liver metabolic enzymes and mammary gland glucose transporters during the transition from pregnancy to lactation. PLoS One (2013) 0.80
Breast carcinoma progression and tumour vascular markers related to apoptotic mechanisms. Dis Markers (2014) 0.79
The Role of Nitric Oxide Synthase Uncoupling in Tumor Progression. Mol Cancer Res (2015) 0.79
A high-content, multiplexed screen in human breast cancer cells identifies profilin-1 inducers with anti-migratory activities. PLoS One (2014) 0.79
The type 7 serotonin receptor, 5-HT 7 , is essential in the mammary gland for regulation of mammary epithelial structure and function. Biomed Res Int (2015) 0.77
Aspartic acid substitutions in monoamine oxidase-A reveal both catalytic-dependent and -independent influences on cell viability and proliferation. J Neural Transm (Vienna) (2012) 0.76
Androgen suppresses testicular cancer cell growth in vitro and in vivo. Oncotarget (2016) 0.75
Generation of 2,000 breast cancer metabolic landscapes reveals a poor prognosis group with active serotonin production. Sci Rep (2016) 0.75
RNA Sequencing Analysis Reveals Interactions between Breast Cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis. Biomed Res Int (2017) 0.75
PPARγ targeted oral cancer treatment and additional utility of genomics analytic techniques. Laryngoscope (2016) 0.75
DNA Methylation Patterns in Rat Mammary Carcinomas Induced by Pre- and Post-Pubertal Irradiation. PLoS One (2016) 0.75
Tryptophan hydroxylase 1 and 5-HT7 receptor preferentially expressed in triple-negative breast cancer promote cancer progression through autocrine serotonin signaling. Mol Cancer (2016) 0.75
Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer. Oncotarget (2016) 0.75
The hallmarks of cancer. Cell (2000) 113.05
Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002) 71.36
A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med (2002) 58.15
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet (2005) 29.45
The clonal evolution of tumor cell populations. Science (1976) 24.39
Genes that mediate breast cancer metastasis to lung. Nature (2005) 19.85
Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature (2005) 19.56
Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell (2009) 16.06
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst (2006) 14.60
Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles. Neoplasia (2007) 10.74
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series. Clin Cancer Res (2007) 8.41
Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res (2006) 8.08
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. J Clin Oncol (2006) 7.24
X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell (2006) 7.17
Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell (2008) 5.93
Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med (1985) 5.82
Identification of molecular apocrine breast tumours by microarray analysis. Oncogene (2005) 5.27
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer. Genome Biol (2007) 4.70
The two faces of transforming growth factor beta in carcinogenesis. Proc Natl Acad Sci U S A (2003) 4.41
Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res (1997) 4.22
Breast cancer: origins and evolution. J Clin Invest (2007) 3.31
Co-evolution of tumor cells and their microenvironment. Trends Genet (2008) 3.08
p38 mitogen-activated protein kinase is required for TGFbeta-mediated fibroblastic transdifferentiation and cell migration. J Cell Sci (2002) 3.07
High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer (2005) 3.07
Platelet-derived serotonin mediates liver regeneration. Science (2006) 2.98
Growth control and cyclic alterations of cyclic AMP in the cell cycle. Nat New Biol (1972) 2.93
Difference in the cyclic adenosine 3',5'-monophosphate levels in normal and transformed cells. Nat New Biol (1972) 2.90
Inhibition of cell growth in vitro by adenosine 3',5'-monophosphate. Science (1968) 2.72
Serotonin regulates mammary gland development via an autocrine-paracrine loop. Dev Cell (2004) 2.40
Disruption of the nonneuronal tph1 gene demonstrates the importance of peripheral serotonin in cardiac function. Proc Natl Acad Sci U S A (2003) 2.19
Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis. Am J Pathol (2006) 1.83
Prognosis and gene expression profiling of 20q13-amplified breast cancers. Clin Cancer Res (2006) 1.75
Human breast development. J Mammary Gland Biol Neoplasia (2000) 1.71
Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity. Am J Pathol (1998) 1.71
Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev (1994) 1.68
E-cadherin as a tumor (invasion) suppressor gene. Bioessays (1995) 1.62
Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole. Pharmacogenet Genomics (2007) 1.60
Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res (2008) 1.59
Coated-platelets: an emerging component of the procoagulant response. J Thromb Haemost (2005) 1.57
Microenvironment of the involuting mammary gland mediates mammary cancer progression. J Mammary Gland Biol Neoplasia (2007) 1.50
Autocrine/paracrine regulation of the growth of the biliary tree by the neuroendocrine hormone serotonin. Gastroenterology (2005) 1.38
Mammary gland involution as a multi-step process. J Mammary Gland Biol Neoplasia (2007) 1.23
Reproductive state of rat mammary gland stroma modulates human breast cancer cell migration and invasion. Cancer Res (2000) 1.21
Mammary gland homeostasis employs serotonergic regulation of epithelial tight junctions. Proc Natl Acad Sci U S A (2007) 1.19
Serotonin: a review. J Vet Pharmacol Ther (2008) 1.19
Serotonin metabolism is dysregulated in cholangiocarcinoma, which has implications for tumor growth. Cancer Res (2008) 1.18
Role of serotonin in the hepato-gastroIntestinal tract: an old molecule for new perspectives. Cell Mol Life Sci (2008) 1.18
The organization of tight junctions in epithelia: implications for mammary gland biology and breast tumorigenesis. J Mammary Gland Biol Neoplasia (2003) 1.18
Serotoninergic receptors on human airway epithelial cells. Am J Respir Cell Mol Biol (2006) 1.18
Biphasic regulation of mammary epithelial resistance by serotonin through activation of multiple pathways. J Biol Chem (2008) 1.13
Mammary stem cell number as a determinate of breast cancer risk. Breast Cancer Res (2007) 1.12
Role of cyclic nucleotides in cancer. Adv Cyclic Nucleotide Res (1974) 1.11
Adenosine 3',5'-cyclic monophosphate and contact inhibition. Cancer Res (1971) 1.11
A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors. Clin Cancer Res (2006) 1.09
Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors. Eur J Cancer (2005) 1.09
Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques. Eur J Pharmacol (1999) 1.09
Inhibition of photocarcinogenesis by platelet-activating factor or serotonin receptor antagonists. Cancer Res (2008) 1.09
The basic pathology of human breast cancer. J Mammary Gland Biol Neoplasia (2000) 1.07
Recent translational research: stem cells as the roots of breast cancer. Breast Cancer Res (2006) 1.06
c-AMP and the cell cycle: inhibition of growth stimulation. Exp Cell Res (1973) 1.06
Challenges to defining a role for progesterone in breast cancer. Steroids (2007) 1.04
Organization and expression of the human zo-2 gene (tjp-2) in normal and neoplastic tissues. Biochim Biophys Acta (2000) 1.03
Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells. Oncogene (2006) 1.03
Evaluation of serotonin as a feedback inhibitor of lactation in the bovine. J Dairy Sci (2008) 1.01
The role of serotonin (5-hydroxytryptamine1A and 1B) receptors in prostate cancer cell proliferation. J Urol (2006) 1.00
SEMP1, a senescence-associated cDNA isolated from human mammary epithelial cells, is a member of an epithelial membrane protein superfamily. Gene (1999) 1.00
Apoptosis and autophagy in mammary gland remodeling and breast cancer chemotherapy. J Physiol Pharmacol (2006) 0.99
The role of serotonin in tumour growth (review). Oncol Rep (2005) 0.99
The 5-HT2A serotoninergic receptor is expressed in the MCF-7 human breast cancer cell line and reveals a mitogenic effect of serotonin. Biochem Biophys Res Commun (2006) 0.97
Hormonal control of insulin-like growth factor-binding protein-5 production in the involuting mammary gland of the rat. Endocrinology (1997) 0.96
Expression and targeting of the tight junction protein CLDN1 in CLDN1-negative human breast tumor cells. J Cell Physiol (2002) 0.96
Pulmonary neuroendocrine cells (PNEC) and neuroepithelial bodies (NEB): chemoreceptors and regulators of lung development. Paediatr Respir Rev (2001) 0.91
5-HT and the brain-gut axis: opportunities for pharmacologic intervention. Expert Opin Investig Drugs (2007) 0.91
The influence of growth factors on the proliferative potential of normal and primary breast cancer-derived human breast epithelial cells. Breast Cancer Res Treat (1991) 0.89
Progesterone action and responses in the alphaERKO mouse. Steroids (2000) 0.88
Vasoactive peptides in cardiovascular (patho)physiology. Expert Rev Cardiovasc Ther (2007) 0.88
Is breast tumor progression really linear? Clin Cancer Res (2008) 0.87
Conversion of 5-hydroxytryptophan into serotonin by tryptophan decarboxylase in plants, Escherichia coli, and yeast. Biosci Biotechnol Biochem (2008) 0.86
Differences in agonist-independent and -dependent 5-hydroxytryptamine2C receptor-mediated cell division. Mol Pharmacol (1996) 0.84
5-hydroxytryptamine strongly inhibits fluid secretion in guinea pig pancreatic duct cells. J Clin Invest (2001) 0.81
Evidence for receptor subtype cross-talk in the mitogenic action of serotonin on human small-cell lung carcinoma cells. Eur J Pharmacol (1996) 0.81
Enhancement of maternal lactation performance during prolonged lactation in the mouse by mouse GH and long-R3-IGF-I is linked to changes in mammary signaling and gene expression. J Endocrinol (2008) 0.79
Neurohormonal control of pancreatic exocrine secretion. Curr Opin Gastroenterol (2002) 0.77
Expression of 5-HT2B and 5-HT2C receptor genes is associated with proliferative regions of Xenopus developing brain and eye. Brain Res Mol Brain Res (2003) 0.77
Neuroendocrine cells in the vestibular glands of the genital tract of cows and pigs. Acta Histochem (2006) 0.76
Expression of 5-HT2A and 5-HT1B receptor mRNA in blood vessels. Mol Cell Biochem (1999) 0.76
Serotonin regulates mammary gland development via an autocrine-paracrine loop. Dev Cell (2004) 2.40
Induction of CYP3A4 by efavirenz in primary human hepatocytes: comparison with rifampin and phenobarbital. J Clin Pharmacol (2004) 1.79
Receptor activator of NF-kappaB ligand induction via Jak2 and Stat5a in mammary epithelial cells. J Biol Chem (2003) 1.43
RNA sequencing of the human milk fat layer transcriptome reveals distinct gene expression profiles at three stages of lactation. PLoS One (2013) 1.42
Investigation of the transcriptional changes underlying functional defects in the mammary glands of prolactin receptor knockout mice. Recent Prog Horm Res (2003) 1.20
Mammary gland homeostasis employs serotonergic regulation of epithelial tight junctions. Proc Natl Acad Sci U S A (2007) 1.19
Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines. Neoplasia (2010) 1.15
Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy. Prostate (2007) 1.14
Biphasic regulation of mammary epithelial resistance by serotonin through activation of multiple pathways. J Biol Chem (2008) 1.13
Decidual prolactin silences the expression of genes detrimental to pregnancy. Endocrinology (2007) 1.11
Autocrine prolactin induced by the Pten-Akt pathway is required for lactation initiation and provides a direct link between the Akt and Stat5 pathways. Genes Dev (2012) 1.04
Induction of cytochrome P450 3A4 in primary human hepatocytes and activation of the human pregnane X receptor by tamoxifen and 4-hydroxytamoxifen. Drug Metab Dispos (2002) 0.99
The xc- cystine/glutamate antiporter as a potential therapeutic target for small-cell lung cancer: use of sulfasalazine. Cancer Chemother Pharmacol (2008) 0.99
Cannabinoid receptor I activation markedly inhibits human decidualization. Mol Cell Endocrinol (2005) 0.99
Sulfasalazine-induced reduction of glutathione levels in breast cancer cells: enhancement of growth-inhibitory activity of Doxorubicin. Chemotherapy (2007) 0.97
Prolactin and transforming growth factor-beta signaling exert opposing effects on mammary gland morphogenesis, involution, and the Akt-forkhead pathway. Mol Endocrinol (2004) 0.96
The prolactin-deficient mouse has an unaltered metabolic phenotype. Endocrinology (2006) 0.94
Rapid eye movement sleep is reduced in prolactin-deficient mice. J Neurosci (2005) 0.93
Suppression of cystine uptake by sulfasalazine inhibits proliferation of human mammary carcinoma cells. Anticancer Res (2004) 0.93
Prolactin suppresses glucocorticoid-induced thymocyte apoptosis in vivo. Endocrinology (2003) 0.92
The bovine mammary gland expresses multiple functional isoforms of serotonin receptors. J Endocrinol (2009) 0.91
Cellular and molecular studies on cisplatin-induced apoptotic cell death in rat kidney. Arch Toxicol (2003) 0.91
Two tandemly linked interferon-gamma-activated sequence elements in the promoter of glycosylation-dependent cell adhesion molecule 1 gene synergistically respond to prolactin in mouse mammary epithelial cells. Mol Endocrinol (2003) 0.91
In vitro multipotent differentiation and barrier function of a human mammary epithelium. Cell Tissue Res (2008) 0.91
Pituitary tumorigenesis in prolactin gene-disrupted mice. Endocrinology (2002) 0.90
A standardized nomenclature for the mouse and rat prolactin superfamilies. Mamm Genome (2007) 0.90
Lactation and neonatal nutrition: defining and refining the critical questions. J Mammary Gland Biol Neoplasia (2012) 0.89
Serotonin transport and metabolism in the mammary gland modulates secretory activation and involution. J Clin Endocrinol Metab (2009) 0.89
Effects of prolactin deficiency on myelopoiesis and splenic T lymphocyte proliferation in thermally injured mice. Endocrinology (2002) 0.89
Nitric oxide mediates increased P-glycoprotein activity in interferon-{gamma}-stimulated human intestinal cells. Am J Physiol Gastrointest Liver Physiol (2004) 0.89
Role of human pregnane X receptor in tamoxifen- and 4-hydroxytamoxifen-mediated CYP3A4 induction in primary human hepatocytes and LS174T cells. Drug Metab Dispos (2008) 0.89
Mammary gland serotonin regulates parathyroid hormone-related protein and other bone-related signals. Am J Physiol Endocrinol Metab (2012) 0.86
Reduced expression of organic cation transporters rOCT1 and rOCT2 in experimental diabetes. J Pharmacol Exp Ther (2004) 0.86
High fat diet alters lactation outcomes: possible involvement of inflammatory and serotonergic pathways. PLoS One (2012) 0.86
Prolactin regulates mammary epithelial cell proliferation via autocrine/paracrine mechanism. Endocrine (2003) 0.86
Differences in the induction of cytochrome P450 3A4 by taxane anticancer drugs, docetaxel and paclitaxel, assessed employing primary human hepatocytes. Cancer Chemother Pharmacol (2004) 0.84
Extracellular glucose concentration alters functional activity of the intestinal oligopeptide transporter (PepT-1) in Caco-2 cells. J Pharm Sci (2003) 0.84
Effects of housing on the thymic deficiency in dwarf mice and its reversal by growth hormone administration. Clin Immunol (2003) 0.84
Effects of prolactin level on burn-induced aberrations in myelopoiesis. Shock (2004) 0.84
Decidual activin: its role in the apoptotic process and its regulation by prolactin. Biol Reprod (2002) 0.83
Dose-dependent induction of cytochrome P450 (CYP) 3A4 and activation of pregnane X receptor by topiramate. Epilepsia (2003) 0.82
Completely humanizing prolactin rescues infertility in prolactin knockout mice and leads to human prolactin expression in extrapituitary mouse tissues. Endocrinology (2013) 0.82
Multiple cellular responses to serotonin contribute to epithelial homeostasis. PLoS One (2011) 0.82
Identification of HRPAP20: a novel phosphoprotein that enhances growth and survival in hormone-responsive tumor cells. Cancer Res (2004) 0.81
Intraluminal volume homeostasis: A common sertonergic mechanism among diverse epithelia. Commun Integr Biol (2011) 0.80
Serotonin (5-HT) affects expression of liver metabolic enzymes and mammary gland glucose transporters during the transition from pregnancy to lactation. PLoS One (2013) 0.80
Mice treated with a benzodiazepine had an improved survival rate following Pseudomonas aeruginosa infection. J Burn Care Res (2010) 0.78
Induction of cytochrome P450 3A by paclitaxel in mice: pivotal role of the nuclear xenobiotic receptor, pregnane X receptor. Drug Metab Dispos (2003) 0.78
Prolactin receptor diversity in humans: novel isoforms suggest general principles. Trends Endocrinol Metab (2002) 0.77
Aldolase C/zebrin gene regulation by prolactin during pregnancy and lactation. Endocrine (2003) 0.77
Serotonin regulates calcium homeostasis in lactation by epigenetic activation of hedgehog signaling. Mol Endocrinol (2014) 0.76
Serotonin and serotonin transport in the regulation of lactation. J Mammary Gland Biol Neoplasia (2013) 0.76
Cortactin-binding protein 90 (CBP90) expression in the mouse mammary glands during prolactin-induced lobuloalveolar development. Zoolog Sci (2002) 0.75
Psychogenic stress prior to burn injury has differential effects on bone marrow and cytokine responses. Exp Biol Med (Maywood) (2007) 0.75
Prolactin Regulation of pim-1 Expression: Positive and Negative Promoter Elements1. Endocrinology (1999) 0.75
Stress and prolactin effects on bone marrow myeloid cells, serum chemokine and serum glucocorticoid levels in mice. Neuroimmunomodulation (2008) 0.75
Glycosylation-Dependent Cell Adhesion Molecule 1 (GlyCAM 1) Is Induced by Prolactin and Suppressed by Progesterone in Mammary Epithelium* * This work was supported by National Institutes of Health. Endocrinology (2000) 0.75